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Work  done in  this  laboratory  (1-6)  has  shown that  the  anti-H-Y  cytotoxic 
response in mice is regulated by two or three genes in the H-2 complex: one of 
these genes is located in the H-2K or H-2D region, and its products serve as the 
associative structure for the H-Y antigen in the induction and effector phase of 
T-cell  cytotoxicity.  Of  the  other  types  of  regulatory  genes,  Ir  genes,  the 
dominant  gene  of the  H-2 b haplotype  maps  in  the  IA  region,  whereas  the 
complementary genes of other haplotypes map in the IC region. The presence of 
these Ir genes is also necessary for anti-H-Y cytotoxicity to occur. 
The  rejection  of syngeneic  male  skin  grafts  by females  of various  mouse 
strains has been extensively studied (7), and it has been shown that the ability 
of females  to  reject  syngeneic  male  skin  is  largely  determined  by the  H-2 
complex (8, 9), but in some cases non-H-2 genes may have an effect on rejection 
(8,  10,  11).  Mapping data obtained by using inbred recombinant mouse strains 
indicate  that  genes  causing  rapid  rejection  of syngeneic  male  skin  grafts  by 
female mice localize near the K-end Of the H-2 b haplotype (12). Our findings on 
the Ir gene regulation  of the anti-H-Y cytotoxic cell formation now make the 
comparison of these two phenomena possible. 
Materials  and  Methods 
Mice.  All mice used were obtained from the breeding unit of the Division of Comparative 
Medicine at the Clinical Research Centre, Harrow, England. Their H-2 haplotypes are indicated 
in Table I. 
Skin Grafting.  Skin grafting was done as described by Billingham and Medawar (13). Full- 
thickness skin grafts, ~-0.5 ×  1.0 cm from the tail, were grafted onto the side of the thorax of the, 
recipient, and protected for 9-11 days by a plaster bandage. Rejection was scored macroscopically 
three times a week for 100 days. The results are expressed as a median survival time of the graft 
(rejection in 50% of mice in a group). The statistical significance was determined by a computer- 
ized log rank test (14). 
Results 
To compare the rejection of syngeneic male skin grafts with the induction of 
anti-H-Y cytotoxic cell formation, we used the previously described methods to 
examine  the  ability of various  inbred  mouse strains  and  their  F1  hybrids to 
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TABLE  I 
H-2 Haplotypes of Mice Used 
769 
Strains 
H-2 Regions 
K  A  B  J  E  C  S  G  D 
C57BL/10  b  b  b  b  b  b  b  b  b 
B10.S  s  s  s  s  s  s  s  s  s 
B10.G  q  q  q  q  q  q  q  q  q 
CBA, B10.BR  k  k  k  k  k  k  k  k  k 
BALB/c, B10.D2  d  d  d  d  d  d  d  d  d 
B10.A(2R)  k  k  k  k  k  d  d  d  b 
B10.A(4R)  k  k  b  b  b  b  b  b  b 
B10.A(5R)  b  b  b  k  k  d  d  d  d 
A, B10.A  k  k  k  k  k  d  d  d  d 
C3H.OH  d  d  d  d  d  d  d  d  k 
HTI  b  b  b  b  b  b  b  b  d 
B10.HTG  d  d  d  d  d  d  d  d  b 
A.TL  s  k  k  k  k  k  k  k  d 
mount an anti-H-Y cytotoxic response (1-6). In brief, female mice were primed 
with male spleen cells intraperitoneally,  or with a  male skin graft,  and spleen 
cells  from  these  mice  were  then  restimulated  in  vitro  in  mixed  lymphocyte 
culture  with the  male spleen  cells from the  strain  used for priming.  Priming 
with spleen cells or by skin grafting has always given identical results and,  in 
fact,  there  is  evidence  that  in  skin  grafting,  the  passenger  leukocytes  are 
responsible for the priming of the recipient (15). In Tables II-IV, the capacity of 
cytotoxic cell production is indicated  as positive or negative. The criteria for a 
positive result are set out in the accompanying paper (6) and are shown in detail 
in that paper. 
Female mice of various inbred strains were first grafted with syngeneic male 
skin.  Early rejection was associated with the H-2 b haplotype: in B10 and in the 
recombinant strains having a  part of the H-2 b haplotype (B10.A(4R),  B10.A(5R) 
and HTI), the median survival time of the graft varied from 21 to 65 days (Table 
II), but the differences between these strains were not statistically significant. 
In  all  the  other  strains,  only one or two  grafts were  rejected  in  100  days  (in 
every group, P  <  0.01 when compared to B10.A(5R) group).  We used B10.HTG 
mice instead  of HTG, and the  absence of rejection in  these  mice confirms the 
findings of Gasser and Shreffler (11) that the male skin graft rejection by HTG 
females is caused by genes outside H-2.  Of those  mouse strains  able to reject 
50%  of skin  grafts in  less than  65  days,  only  B10  mice were  able  to  mount  a 
secondary cytotoxic reaction against syngeneic male cells in vitro. Of the strains 
unable to reject grafts, only C3H.OH was able to produce cytotoxic cells. 
In studies on the dominance of the  genes causing rapid  skin graft rejection 
(Table  III), it  was  found  that  (B10  x  BALB/c)F1  females  rejected  male  skin 
grafts from either parental  strain,  and this  rejection was accompanied by the 
ability  to  mount  a  cytotoxic response.  Similar results  have been  obtained for 
example with (B10  x  CBA)F1 females (data not shown). The dominance of H-2 b 
gene(s)  in  skin  graft rejection was also seen in  the  experiments with  (HTI  x 
B10.A(2R))F1  and  (BALB/c  x  B10.A(5R))F1  females,  but  in  contrast  to  the 770  T-CELL  CYTOTOXICITY  IN  MALE  SKIN  GRAFT  REJECTION 
TABLE  II 
Syngeneic Male Skin Graft Rejection  by Female Mice of Various Inbred Strains 
Anti-H-Y 
No.  in  Median survival 
cytotoxic-  Recipient  9  Donor c;  group  time  ity 
days 
B10  B10  11  40  + 
CBA  CBA  15  >100  - 
BALB/c  BALB/c  14  >100  - 
B10.S  B10.S  11  >100  - 
B10.G  B10.G  11  >100  - 
B10.BR  B10.BR  10  >100  - 
B10.D2  B10.D2  10  >100  - 
BI0.A  BI0.A  14  >I00  - 
BI0.A(2R)  B10.A(2R)  i0  >I00  - 
BI0.A(4R)  BI0.A(4R)  13  65  - 
BI0.A(5R)  BI0.A(5R)  10  21  - 
HTI  HTI  13  49  - 
A.TL  A.TL  i0  >i00  - 
C3H.OH  C3H.OH  19  > I00  + 
B10.HTG  B10.HTG  7  >100  - 
TABLE Ill 
Rejection  of Parental Male Skin Graft by F, Hybrid Females Derived from Matings 
with One Parent Carrying All or Part of the H-2 b Haplotype 
Anti-H- 
No. in  Median sur- 
Y cyto-  Recipient  ~  Donor d  group  vival time  toxicity 
days 
(B10  x  BALB/c)F,  B10  12  53  + 
(B10  x  BALB/c)F,  BALB/c  12  41  + 
(B10  x  B10.D2)F,  B10  6  42  + 
(B10  x  B10.D2)F,  B10.D2  6  47  + 
(HTI x  B10.A(2R))F,  HTI  10  53  - 
(HTI ×  B10.A(2R))F,  B10.A(2R)  8  41  + 
(BALB/c  ×  B10.A(5R))F,  BALB/c  9  33  + 
(BALB/c  x  B10.A(5R))F,  B10.A(5R)  9  28  - 
(Bi0  x  A.TL)F,  B10  8  47  + 
(B10  x  A.TL)F,  A.TL  6  >100  - 
results with  (B10  x  BALB/c)F, mice,  no cytotoxic response could be mounted 
after graftings  with HTI and B10.A(5R) male skin,  respectively.  Concomitant 
absence of skin graft rejection and cytotoxic cell production was noticed in (B10 
x  A.TL)F1 females grafted with A.TL male skin. 
The  grafting  results  with  F,  hybrids  derived  from  matings  of strains  not 
involving the H-2 b haplotype and unable to reject male skin grafts were clear: 
the male skin grafts from either parental strain were not rejected regardless of 
their capacity to produce cytotoxic cells (Table IV). 
Using  B10  background  H-2  congenic  mouse  strains,  some  of the  strain 
combinations using noncongenic strains shown in Tables III and IV were tested 
for both  graft  rejection  and  generation  of cytotoxic anti-H-Y  responses.  The HURME~  CHANDLER,  HETHERINGTON,  AND  SIMPSON  771 
TABLE  IV 
Rejection of  Parental Male Skin Grafts by F1 Hybrid Females Derived from Matings of 
Two Nonresponder Strains 
No.  in 
Recipient  ~  Donor 
group 
Median  Anti-H- 
survival  Y  cyto- 
time  toxicity 
days 
(CBA  x  BALB/c)F,  CBA  10  >100  + 
(CBA  x  BALB/c)F,  BALB/c  10  >100  - 
(B10.BR  x  BI0.D2)F,  B10.BR  8  >100  + 
(B10.BR  x  B10.D2)F,  B10.D2  7  >100  - 
(CBA  x  A)F,  CBA  11  >100  + 
(CBA  x  A)F,  A  9  >100  - 
(CBA  x  B10.S)F,  CBA  10  >100  + 
(CBA  x  B10.S)F,  B10.S  9  >100  + 
(B10.A(2R)  x  B10.S)F,  B10.A(2R)  14  >100  - 
(B10.A(2R)  x  B10.S)F,  B10.S  12  >100  - 
(B10.G  x  B10.S)F,  B10.G  13  >100  - 
(B10.G  x  B10.S)F,  B10.S  15  >100  + 
results were always concordant with those shown, and they indicate that non- 
H-2 genes were not involved. 
Discussion 
The results show that the genes enabling rapid rejection of syngeneic male 
skin grafts by female mice are not the same as those that enable the production 
of H-2-restricted anti-H-Y cytotoxic cells. Thus, by using suitable recombinant 
mouse strains and F1 hybrids, skin graft rejection without concomitant produc- 
tion of anti-H-Y cytotoxic cell formation has been obtained and vice versa. 
Table V shows a  summary of these results.  Only mice with all or part of the 
H-2 b haplotype could reject grafts.  The common part of the H-2 b haploytpe in 
mice able to reject male skin grafts is.the IB region.  Regardless of the presence 
ofIB ~ in all of these strains,  the variations in graft survival time indicate that 
other  parts  of the  H-2  may  have  a  regulatory  effect.  These  results  are  in 
agreement  with those of Bailey (12),  but Bailey's orthotopic tailskin  grafting 
method is more sensitive. His graft survival times were thus much shorter than 
ours,  and some of our nonrejector strains  could be classified as slow rejectors. 
B10.A(SR)  and  HTI  strains  also  have  the IA b region  which  contains  the Ir 
gene(s)  for  anti-H-Y  cytotoxic cell  production  (6),  but  both  strains  lack  the 
proper associative antigen  for the induction  of a  cytotoxic response  (we have 
never obtained an anti-H-Y response associated with H-2K  b- or H-2Dd-region 
products).  B10.A(4R),  having  IA  k and  IB  b,  are  able to  reject syngeneic male 
skin grafts due to the presence of IB  b, but they are unable to produce cytotoxic 
cells  due  to  the  absence  of IA  b,  regardless  of the  presence  of appropriate 
associative antigens  (H-2D  b and H-2Kk). This confirms a  different localization 
of those Ir genes controlling skin graft rejection  and those enabling cytotoxic 
cell production in mice carrying the H-2 b haplotype.  Both of these genes show 
dominant  character,  but  the  cytotoxic response  needs  the  proper  associative 
antigen to occur, thus, for example (B10 x  BALB/c)F1 females are able to reject 772  T-CELL CYTOTOXICITY IN  MALE SKIN GRAFT REJECTION 
TABLE V 
Mouse Strains and FI Hybrids with Negative Correlation 
between Capacity to Produce an Anti-H-Y Cytotoxic Response 
and the Rejection  of Male Skin Grafts  by Female Mice* 
Recipient £  Donor c~ 
Skin graft rejection without cytotoxic cell 
production 
B10.A(4R)  B10.A(4R) 
B10.A(5R)  B10.A(5R) 
HTI  HTI 
(HTI x B10.A(2R))F,  HTI 
(BALB/c × B10.A(5R))F,  B10.A(5R) 
Cytotoxic  celt production  without skin graft 
rejection 
C3H.OH  C3H.OH 
(CBA × BALB/c)F,  CBA 
(B10.BR x  B10.D2)F1  B10.BR 
(CBA × A)F~  CBA 
(CBA x B10.S)F  1  CBA 
(CBA x B10.S)F  1  B10.S 
(B10.G x B10.S)F1  B10.S 
* For data, see Tables II-IV. 
BALB/c  male  skin  and  to  mount  an  H-2Kd-associated  anti-H-Y  cytotoxic 
response. The lack of dominance of genes causing rapid skin graft rejection was 
noticed in (B10  x  A.TL)F1 females: they did not reject skin grafts from A.TL 
males. It is noteworthy that A.TL mice, having H-2K  s and H-2D  d with which H- 
Y  antigen cannot be associated in the cytotoxic reaction (5),  were not able to 
induce a  cytotoxic response. So in this case, there is a  concomitant absence of 
cytotoxic cell formation and skin graft rejection. This was also true of (B10  x 
A.TH)FI females, which did not reject male skin from A.TH (H-2K  ~,  H-2D d) 
mice (data not shown). 
If the H-2 b genes  causing  rapid  skin  graft rejection were  absent  and  the 
cytotoxic cells were produced by the interaction of complementary Ir genes (H- 
2k/H-2 d, H-2k/H-2L and H-2q/H-2  s complementations), male skin grafts were not 
rejected.  C3H.OH  females  grafted  with  syngeneic  male  skin  were  able  to 
produce  a  cytotoxic  response  but  failed  to  reject  the  graft.  The  possible 
mechanisms  in  cytetoxic cell  formation  in  this  strain  are  discussed  in  the 
accompanying paper  (6).  Those F~  hybrids mentioned in Table IV were also 
regrafted, but second-set rejection was not observed (data not shown). 
In  conclusion,  it  seems  that  H-2-restricted anti-H-Y  cytotoxic T  cells  are 
neither necessary nor sufficient for the rejection of syngeneic male skin grafts, 
and that these two phenomena are even regulated by different genes. This was a 
highly unexpected finding because in allograft rejection the cytotoxic T  cells 
are of prime importance, although the actual rejection phase is probably not an 
autonomous T-cell function (16,  17). So we must assume that syngeneic male 
skin graft rejection is mediated by a different mechanism which is not detectable 
in vitro using the chromium release assay, and that anti-H-Y cytotoxic T cells 
have no in vivo significance. One possibility is that H-2-restricted cytotoxic T HURME,  CHANDLER,  HETHERINGTON,  AND  SIMPSON  773 
cells are not directed against the correct antigen,  and,  in fact, there is recent 
evidence that there are two H-Y antigens.  Melvold et al.  (18) found a  mutant 
(C57BL/6  ×  BALB/c)F1 male  mouse lacking the  H-Y antigen  on the basis of 
skin graft testing, but the serological tests for H-Y antigen were positive. This 
mouse, from an X-irradiated father, had 39 chromosomes and the Y chromosome 
was probably absent (a part of the Y chromosome was probably translocated to 
an  autosome).  They  suggested  the  existence  of two  H-Y  antigens:  H-Y1, 
responsible  for male-female  graft  incompatibility  (part  of the  Y  chromosome 
coding for this antigen was missing in their mouse), and H-Y2, which is defined 
by conventional serological means.  This could explain why strains both which 
do and which do not reject syngeneic male skin grafts may make an antibody 
response against  H-Y  (19),  implying that  anti-H-Y1  and  anti-H-Y2  responses 
are under separate Ir gene control.  If we use this hypothesis in explaining our 
data,  we  must  again  assume  that  anti-H-Y1  response  is  not  mediated  by 
cytotoxic T cells (i.e., is not detectable by chromium release assay) and that we 
have been actually measuring  the cytotoxicity against  H-Y2. Anti°H-Y2 cyto- 
toxicity might not be able to cause skin graft rejection on the basis of different 
concentrations of H-Y1 and H-Y2 antigens on lymphocytes and epidermal cells. 
Kralova and Demant (20) have suggested that the H-2 complex also regulates 
the expression of the H-Y antigen, and the effect of these genes (mapping to the 
left of IC) may be different on thymus and skin cells. For example, in B10.A(SR) 
strain,  the H-Y antigenicity would be strong on thymus cells but weak on skin 
cells.  Their results  show that these genes in the H-2 k  haplotype determine  a 
strong H-Y antigenicity on the skin, whereas the H-2 b haplotype is associated 
with low antigenicity.  In our experiments, these factors seem to have no effect 
on skin graft rejection:  (HTI  x  B10.A(2R))FI females rejected B10.A(2R) and 
HTI male skin at the same rate (Table HI). To rule out the possibility that the 
lack of anti-H-Y  cytotoxic response in  strains  capable of graft  rejection  (e.g. 
B10.A(5R)) was due to low H-Y antigenicity on lymphocytes (normal targets in 
the 5~Cr-release assay), we used syngenic male 5~Cr-labeled epidermal cells as 
targets,  but these results were also negative (unpublished observations). 
Whatever the rejection mechanism  of syngeneic male  graft is,  it is evident 
that the H-Y antigen has some significance in clinical transplantations.  It has 
been reported that female recipients of male kidney grafts survived longer than 
did female recipients of female grafts (21). This might be attributed to anti-H-Y 
antibody enhancement.  But there are other studies which show that the H-Y 
antigen is deleterious for graft survival. Goulmy et al. (22) found a patient with 
aplastic  anemia  who  rejected  a  bone  marrow  graft  from  her  HLA-identical 
brother,  and her lymphocytes were cytotoxic to male cells, but restricted by an 
HLA product in a  manner analogous to the mouse system. 
Summary 
The  ability  of female  mice  to  rapidly  reject  syngeneic  male  skin  grafts  is 
largely determined by dominant genes in the IB region of the H-2 b haplotype, 
whereas  the  ability  to  produce  anti-H-Y  cytotoxic cells  is  determined  by  a 
dominant  gene  in the IA  region of the H-2 b haplotype,  or by complementary 
genes  in  the IC  region  of some  other  haplotypes.  Thus,  it  seems that  H-2- 774  T-CELL  CYTOTOXICITY IN  MALE SKIN  GRAFT REJECTION 
restricted  anti-H-Y  cytotoxic  T  cells  are  not  responsible  for  the  rejection  of 
syngeneic male skin grafts. 
Received for publication 28 October 1977. 
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